Frontiers in pharmacology
Correction: Resveratrol and Angiogenin-2 combined with PEGDA/TCS hydrogel for the targeted therapy of hypoxic bone defects via activation of the autophagy pathway.
Dehui Fan, Hengping Liu, Zhenning Zhang, Meiyi Su, Zhixian Yuan, Ying Lin, Shuquan Yang, Wenqiang Li, Xintao Zhang
Published: 202510.3389/fphar.2025.1597755
Abstract
Open Access[This corrects the article DOI: 10.3389/fphar.2021.618724.].